These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis. Umpierrez GE, Latif K, Stoever J, Cuervo R, Park L, Freire AX, E Kitabchi A. Am J Med; 2004 Sep 01; 117(5):291-6. PubMed ID: 15336577 [Abstract] [Full Text] [Related]
4. Use of intravenous insulin aspart for treatment of naturally occurring diabetic ketoacidosis in dogs. Walsh ES, Drobatz KJ, Hess RS. J Vet Emerg Crit Care (San Antonio); 2016 Sep 01; 26(1):101-7. PubMed ID: 26379102 [Abstract] [Full Text] [Related]
5. Utilizing serum bicarbonate instead of venous pH to transition from intravenous to subcutaneous insulin shortens the duration of insulin infusion in pediatric diabetic ketoacidosis. Gauntt J, Vaidyanathan P, Basu S. J Pediatr Endocrinol Metab; 2019 Jan 28; 32(1):11-17. PubMed ID: 30530908 [Abstract] [Full Text] [Related]
8. Use of lispro insulin for treatment of diabetic ketoacidosis in dogs. Sears KW, Drobatz KJ, Hess RS. J Vet Emerg Crit Care (San Antonio); 2012 Apr 28; 22(2):211-8. PubMed ID: 22390184 [Abstract] [Full Text] [Related]
10. Subcutaneous use of a fast-acting insulin analog: an alternative treatment for pediatric patients with diabetic ketoacidosis. Della Manna T, Steinmetz L, Campos PR, Farhat SC, Schvartsman C, Kuperman H, Setian N, Damiani D. Diabetes Care; 2005 Aug 28; 28(8):1856-61. PubMed ID: 16043723 [Abstract] [Full Text] [Related]
12. Evaluation of NovoRapid infusion as a treatment option in the management of diabetic ketoacidosis. Kwok R, Sztal-Mazer S, Hopkins RE, Poole SG, Grannell L, Coutsouvelis J, Topliss DJ. Intern Med J; 2017 Nov 28; 47(11):1317-1320. PubMed ID: 29105262 [Abstract] [Full Text] [Related]
14. Subcutaneous regular insulin for the treatment of diabetic ketoacidosis in children. Cohen M, Leibovitz N, Shilo S, Zuckerman-Levin N, Shavit I, Shehadeh N. Pediatr Diabetes; 2017 Jun 28; 18(4):290-296. PubMed ID: 27005007 [Abstract] [Full Text] [Related]
16. Basal insulin for the management of diabetic ketoacidosis. Barski L, Brandstaetter E, Sagy I, Jotkowitz A. Eur J Intern Med; 2018 Jan 28; 47():14-16. PubMed ID: 28864157 [Abstract] [Full Text] [Related]
18. Efficacy and Safety of Commonly Used Insulin Analogues in the Treatment of Diabetic Ketoacidosis: A Bayesian Indirect Treatment Comparison. Vidyasagar K, Chandrasekar B, Chhabra M, Bhansali A, Bansal D. Clin Ther; 2020 Aug 28; 42(8):e115-e139. PubMed ID: 32798057 [Abstract] [Full Text] [Related]
19. Insulin glargine supplementation during early management phase of diabetic ketoacidosis in children. Shankar V, Haque A, Churchwell KB, Russell W. Intensive Care Med; 2007 Jul 28; 33(7):1173-1178. PubMed ID: 17508198 [Abstract] [Full Text] [Related]
20. Treatment of diabetic ketoacidosis using normalization of blood 3-hydroxybutyrate concentration as the endpoint of emergency management. A randomized controlled study. Wiggam MI, O'Kane MJ, Harper R, Atkinson AB, Hadden DR, Trimble ER, Bell PM. Diabetes Care; 1997 Sep 28; 20(9):1347-52. PubMed ID: 9283776 [Abstract] [Full Text] [Related] Page: [Next] [New Search]